Hesham Allam, MD

Hesham Allam, MD

Neurologist
Neurology
Accepting new patients
Call for an appointment
217-545-8000
or
Request appointment
Languages:
English, Arabic

    About me

    Gender

    Male

    Additional languages spoken

    Arabic

    Education & training

    Positions
    Associate Professor
    Board Certifications
    Neurology
    Medical School
    Ain Shams University School of Medicine, Cairo, Egypt
    Residency
    Neurology and Psychiatry, Saint Louis University Hospital, Saint Louis, MO
    Fellowship
    Neurocritical Care, Rush University Medical Center, Chicago, IL
    Vascular Neurology, Washington University School of Medicine, St. Louis, IL

    Specialties

    Treatments & procedures

    Patients in waiting room

    Appointments

    SIU Medicine strongly encourages all patients to verify coverage, benefits and which providers are considered in-network with their health plan. SIU Medicine has more than 300 health care providers ready to serve you and your family. SIU Medicine accepts a wide variety of governmental and non-governmental health plans to serve our community. 

    Clinical locations

    Locations

    SIU Neurology Clinic

    751 N. Rutledge St. Springfield, IL 62702 Suite 3100
    Get Directions
    Mon - Fri: 8:00 am-4:30 pm
    217-545-8000
    Locations

    SIU Pulmonology in Decatur

    102 W. Kenwood Ave. Decatur, IL 62526 Lower Level
    Get Directions
    Mon - Fri: 8:00 am-4:30 pm
    217-545-8000

    Hospital privileges

    • Decatur Memorial Hospital, Decatur, IL
    • HSHS St. John's Hospital, Springfield, IL
    • Memorial Health, Springfield IL

    Clinical trials

    Trial
    Neuroscience Institute

    Sleep for Stroke Management and Recovery Trial

    Active recruiting

    The primary goals of this study are to determine whether treatment of obstructive sleep apnea with positive airway pressure starting shortly after accute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event and (2) improves stroke outcomes at 3 months in patients who experienced ischemic stroke.

    Contact: Stephanie Kohlrus 217-545-3013
    Trial
    Neuroscience Institute

    18-513: A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor XA Inhibitor

    Active not recruiting

    18-513:  The purpose of this study is to evaluate the effect of andexanet alfa (andexanet) versus usual care on the rate of effective homostasis.

    Contact: Stephanie Kohlrus 217-545-3013